论文部分内容阅读
目的观察孕三烯酮作为子宫内膜异位症术后辅助治疗药物的疗效。方法对40例子宫内膜异位症患者,术后采用孕三烯酮2.5mg口服,2次/周,疗程3～6个月,观察临床症状;40例未用药,观察术后应用孕三烯酮及未用药患者的复发率。结果用药后40例患者控制症状有效率为90%,复发率为12.5%;未用药患者的复发率为42.5%。结论子宫内膜异位症患者术后服用孕三烯酮可显著改善症状。
Objective To observe the efficacy of gestrinone as adjuvant therapy for endometriosis. Methods Forty patients with endometriosis were treated with gestrinone 2.5mg orally, 2 times / week for 3 ~ 6 months after operation. The clinical symptoms were observed. Recurrence rate of enkephalin and non-medication patients. Results After treatment, the effective rate of symptom control in 40 patients was 90% and the recurrence rate was 12.5%. The recurrence rate of non-medication patients was 42.5%. Conclusion Patients with endometriosis after taking gestrinone can significantly improve the symptoms.